HEALTHPEAK PROPERTIES INC (PEAK)

US42250P1030 - REIT

17.1  +0.35 (+2.09%)

After market: 17.1 0 (0%)

Fundamental Rating

3

PEAK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. While PEAK is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, PEAK is valued expensive at the moment.



5

1. Profitability

1.1 Basic Checks

In the past year PEAK was profitable.
In the past year PEAK had a positive cash flow from operations.
In the past 5 years PEAK has always been profitable.
PEAK had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

PEAK has a Return On Assets of 1.94%. This is in the better half of the industry: PEAK outperforms 65.60% of its industry peers.
With a decent Return On Equity value of 4.79%, PEAK is doing good in the industry, outperforming 68.80% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.45%, PEAK is in line with its industry, outperforming 47.20% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PEAK is in line with the industry average of 3.08%.
The 3 year average ROIC (2.14%) for PEAK is below the current ROIC(2.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROIC 2.45%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%

1.3 Margins

PEAK has a better Profit Margin (13.95%) than 68.00% of its industry peers.
In the last couple of years the Profit Margin of PEAK has declined.
PEAK has a Operating Margin (20.53%) which is in line with its industry peers.
In the last couple of years the Operating Margin of PEAK has declined.
PEAK has a Gross Margin of 59.28%. This is in the lower half of the industry: PEAK underperforms 73.60% of its industry peers.
In the last couple of years the Gross Margin of PEAK has declined.
Industry RankSector Rank
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PEAK is destroying value.
The number of shares outstanding for PEAK remains at a similar level compared to 1 year ago.
Compared to 5 years ago, PEAK has more shares outstanding
Compared to 1 year ago, PEAK has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that PEAK is in the distress zone and has some risk of bankruptcy.
PEAK has a worse Altman-Z score (0.34) than 64.80% of its industry peers.
PEAK has a debt to FCF ratio of 32.87. This is a negative value and a sign of low solvency as PEAK would need 32.87 years to pay back of all of its debts.
PEAK has a Debt to FCF ratio (32.87) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.08 is on the high side and indicates that PEAK has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.08, PEAK is in line with its industry, outperforming 53.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Altman-Z 0.34
ROIC/WACC0.37
WACC6.55%

2.3 Liquidity

PEAK has a Current Ratio of 0.14. This is a bad value and indicates that PEAK is not financially healthy enough and could expect problems in meeting its short term obligations.
PEAK's Current ratio of 0.14 is on the low side compared to the rest of the industry. PEAK is outperformed by 96.80% of its industry peers.
PEAK has a Quick Ratio of 0.14. This is a bad value and indicates that PEAK is not financially healthy enough and could expect problems in meeting its short term obligations.
PEAK has a Quick ratio of 0.14. This is amonst the worse of the industry: PEAK underperforms 96.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14

4

3. Growth

3.1 Past

PEAK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.86%.
PEAK shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.30% yearly.
The Revenue has been growing slightly by 5.81% in the past year.
Measured over the past years, PEAK shows a quite strong growth in Revenue. The Revenue has been growing by 12.86% on average per year.
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%

3.2 Future

The Earnings Per Share is expected to decrease by -3.48% on average over the next years.
PEAK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.55% yearly.
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 30.54, PEAK can be considered very expensive at the moment.
Based on the Price/Earnings ratio, PEAK is valued a bit cheaper than 61.60% of the companies in the same industry.
When comparing the Price/Earnings ratio of PEAK to the average of the S&P500 Index (27.54), we can say PEAK is valued inline with the index average.
A Price/Forward Earnings ratio of 43.73 indicates a quite expensive valuation of PEAK.
Based on the Price/Forward Earnings ratio, PEAK is valued a bit cheaper than 65.60% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.99, PEAK is valued quite expensively.
Industry RankSector Rank
PE 30.54
Fwd PE 43.73

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PEAK is valued a bit cheaper than 62.40% of the companies in the same industry.
PEAK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 44.73
EV/EBITDA 13.46

4.3 Compensation for Growth

PEAK's earnings are expected to decrease with -5.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%

5

5. Dividend

5.1 Amount

PEAK has a Yearly Dividend Yield of 7.02%, which is a nice return.
Compared to an average industry Dividend Yield of 16.05, PEAK pays a bit more dividend than its industry peers.
PEAK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 7.02%

5.2 History

The dividend of PEAK decreases each year by -11.76%.
PEAK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-11.76%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

215.92% of the earnings are spent on dividend by PEAK. This is not a sustainable payout ratio.
The Dividend Rate of PEAK has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP215.92%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%

HEALTHPEAK PROPERTIES INC

NYSE:PEAK (3/1/2024, 8:04:00 PM)

After market: 17.1 0 (0%)

17.1

+0.35 (+2.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-08 2024-02-08/amc
Earnings (Next)N/A N/A
Inst Owners117.78%
Inst Owner Change0.5%
Ins Owners0.15%
Ins Owner Change0%
Market Cap9.36B
Analysts78.18
Price Target22.19 (29.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.02%
Dividend Growth(5Y)-11.76%
DP215.92%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-13 2024-02-13 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.48%
Min EPS beat(2)25.88%
Max EPS beat(2)43.09%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-17.64%
Max EPS beat(4)149.96%
EPS beat(8)6
Avg EPS beat(8)80.62%
EPS beat(12)9
Avg EPS beat(12)65.46%
EPS beat(16)12
Avg EPS beat(16)81.29%
Revenue beat(2)1
Avg Revenue beat(2)-0.5%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-1.62%
Max Revenue beat(4)0.62%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)3
Avg Revenue beat(12)-1.7%
Revenue beat(16)3
Avg Revenue beat(16)-8.89%
PT rev (1m)-1.34%
PT rev (3m)2.46%
EPS NQ rev (1m)-15.62%
EPS NQ rev (3m)-7.95%
EPS NY rev (1m)-12.55%
EPS NY rev (3m)-6.5%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)6.65%
Revenue NY rev (3m)16.7%
Valuation
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
P/S 4.29
P/FCF 44.73
P/OCF 9.78
P/B 1.47
P/tB 1.55
EV/EBITDA 13.46
EPS(TTM)0.56
EY3.27%
EPS(NY)0.39
Fwd EY2.29%
FCF(TTM)0.38
FCFY2.24%
OCF(TTM)1.75
OCFY10.22%
SpS3.99
BVpS11.61
TBVpS11.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROCE 3.1%
ROIC 2.45%
ROICexc 2.47%
ROICexgc 2.68%
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
FCFM 9.59%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
ROICexc(3y)2.16%
ROICexc(5y)1.9%
ROICexgc(3y)2.33%
ROICexgc(5y)2.05%
ROCE(3y)2.71%
ROCE(5y)2.39%
ROICexcg growth 3Y28.26%
ROICexcg growth 5Y4.6%
ROICexc growth 3Y28.51%
ROICexc growth 5Y3.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Debt/EBITDA 5.74
Cap/Depr 99.62%
Cap/Sales 34.25%
Interest Coverage 2.38
Cash Conversion 79.85%
Profit Quality 68.75%
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 0.34
F-Score6
WACC6.55%
ROIC/WACC0.37
Cap/Depr(3y)183.97%
Cap/Depr(5y)234.29%
Cap/Sales(3y)65.04%
Cap/Sales(5y)98.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A
EBIT growth 1Y13.63%
EBIT growth 3Y27.09%
EBIT growth 5Y6.6%
EBIT Next Year208.15%
EBIT Next 3Y49.06%
EBIT Next 5Y31.97%
FCF growth 1Y249.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.21%
OCF growth 3Y8.03%
OCF growth 5Y2.41%